
I'm a neurologist—to keep my 'brain healthy and memory sharp,' I avoid these 4 things that people do all the time
You've probably heard all of this before. It's the standard advice given by doctors and health advocates. And for good reason: This guidance is solid and forms the foundation for long-term health and quality of life.
But there are a few other things many people do all the time that, as a neurologist, I try to avoid to keep my brain healthy and memory sharp.
GPS has made our lives much more convenient. Before its invention, people had to rely on foldout paper maps, spatial reasoning, and environmental cues to navigate. These days, that's become a lost art.
Over time, relying too much on GPS can weaken your spatial memory. One study showed that the hippocampi — the memory centers of the brain — are larger in taxi drivers because they need to memorize complex street layouts.
Another recent study found that taxi and ambulance drivers were less likely to die from Alzheimer's disease than people in other professions. One possible explanation is that these jobs require frequent, real-time use of spatial and navigational skills, which may help maintain or even improve hippocampal health.
This isn't to say people shouldn't use GPS for traffic updates, but there are ways to actively engage your spatial memory without it. For example, try planning a route to a new café or exploring a different way home from work.
Many of us work long days and feel like we never have enough energy to get through them. But relying on energy drinks isn't the solution. These beverages often contain high levels of caffeine, taurine, and B vitamins. Consuming large amounts can lead to cardiovascular issues like high blood pressure, palpitations, and even arrhythmias.
Neurologically, excessive energy drink consumption can cause insomnia, anxiety, restlessness, and, in more severe cases, seizures.
A lesser-known risk is long-term buildup of B vitamins in the body. Normally, excess B vitamins are flushed out naturally since they're water-soluble. However, a notable exception is vitamin B6, often consumed in sports and energy drinks. Excess B6 can accumulate over time, leading to toxicity and potentially causing peripheral neuropathy.
Just because something is available over the counter (OTC) doesn't mean it's harmless. Always follow your doctor's instructions and the medication label, and don't exceed the recommended dosage.
For instance, common side effects of overusing aspirin, ibuprofen, and other NSAIDs (or nonsteroidal anti-inflammatory drugs) include peptic ulcers, GI bleeding, acute kidney injury, and even chronic kidney disease. Tylenol (acetaminophen) is often seen as safer for the stomach and kidneys, but acetaminophen overdose is the leading cause of liver failure in the U.S.
Some lesser-known OTC products can cause surprising side effects. I've seen bismuth toxicity from excessive Pepto-Bismol use lead to dementia-like symptoms. I've also seen patients who, after following advice from online wellness influencers, consumed too much zinc, resulting in spinal cord injuries.
I love hiking and spending time outdoors. But when I venture into nature, I always:
Each year, especially during the summer, I see previously healthy people come into the hospital with fever, confusion, and sometimes seizures or coma, due to mosquito-borne or tick-borne illnesses. Some of these infections, like Lyme disease, are treatable if caught early. Others can leave lasting damage to the brain and nervous system.
Taking small preventive steps to avoid bug bites can potentially save you from life-altering infections.,

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
GPs using fewer physician associates, survey suggests
GPs are cutting back on the use of physician associates (PAs), polling suggests. A new survey, conducted by the GP magazine Pulse, found that 21% of 425 GP networks in England said they had reduced PA numbers in the last year. It comes after the Government-ordered Leng Review found PAs have been used as substitutes for doctors, despite having significantly less training. One of the 18 recommendations in the review was that PAs be banned from seeing patients whom a medic has not reviewed to prevent the risk of 'catastrophic' misdiagnoses. Pulse said that the main reasons GPs gave for cutting back on PAs included: guidance from professional bodies; supervision demands; patient safety concerns and rising complaints. One GP told Pulse: 'We had a PA but now don't use them because of the change in guidance. 'We can't afford to pay someone with such limited scope.' On Friday, the union representing PAs and anaesthesia associates (AAs), United Medical Associate Professionals (UMAPs), lost a High Court bid to temporarily block NHS England from implementing recommended changes from the Leng Review. More than 3,500 PAs and 100 AAs are working in the NHS, and there have been previous calls for an expansion in their number. But their roles were reviewed following high-profile deaths of patients who were misdiagnosed by PAs, with six patient deaths linked to PAs recorded by coroners in England. They include 30-year-old Emily Chesterton, who died from a pulmonary embolism after being misdiagnosed by a PA on two occasions and told she had anxiety. In her report, Professor Gillian Leng concluded there were 'no convincing reasons to abolish the roles of AA or PA' but there was also no case 'for continuing with the roles unchanged'. She said more detail was needed on which patients could be seen by PAs, and national clinical protocols will now be developed in this area. Commenting on the Pulse survey, UMAP general secretary Stephen Nash said: 'Physician associates are highly trained medical professionals who play a vital role in improving patients' access to primary care, particularly in underserved parts of the health service.' He added: 'According to this survey the vast majority of primary care networks are retaining their PA staff. 'This is a testament to PAs' hard work and expertise.'


Medscape
15 hours ago
- Medscape
OTC Birth Control Breaks Access Barriers
TOPLINE: Over-the-counter (OTC) oral contraceptive pill access was linked to a 31.8 percentage point increase in contraceptive initiation among nonusers and a 41.0 percentage point increase in transitioning from less effective methods. More uninsured individuals (31.6% vs 3.5%) and rural residents (14.4% vs 8.4%) accessed OTC options compared to prescription users. METHODOLOGY: A cross-sectional analysis utilized baseline data from a national, prospective, United States cohort study. Participants included 986 individuals, with the largest proportion aged 20-24 years (338 participants [34.3%]) and predominantly single (692 participants [70.2%]). OTC oral contraceptive pill users accounted for 320 (32.5%) of the sample. Researchers recruited individuals aged 15-45 years obtaining oral contraceptive pills at pharmacies or online between April 2024 and February 2025. Analysis focused on comparing outcomes between OTC progestin-only oral contraceptive pill users with prescription oral contraceptive pill users. TAKEAWAY: OTC contraceptive use was associated with a 31.8 percentage point increase (95% confidence interval [CI], 24.1-39.5) in transitioning from nonuse of contraception to oral contraceptive pill use compared with prescription users. Researchers found a 41.0 percentage point increase (95% CI, 33.8-48.1) in transitioning from less-effective contraception methods to oral contraceptive pill use among OTC users. More individuals living in rural areas utilized OTC pills compared to prescription options (46 participants [14.4%] vs 56 participants [8.4%]). The OTC group included higher proportions of Black or Latina individuals, those with lower educational attainment, and residents from the Southern United States. IN PRACTICE: "In this cross-sectional study of people with a biologic capacity for pregnancy in the US obtaining OCPs [oral contraceptive pills] either via traditional prescription pathways or directly OTC, the availability of an OTC OCP was associated with improved contraceptive uptake among individuals at elevated risk of unintended pregnancy. Importantly, OTC OCP users in our sample were more likely to be uninsured and reside in rural areas, underscoring the promise of OTC availability in bridging gaps where health care access is limited. These findings are particularly salient in the context of ongoing threats to reproductive health care access under proposed federal and state-level policy changes," wrote the authors of the study. SOURCE: The study was led by Maria Rodriguez, MD, MPH, Center for Reproductive Health Equity, Oregon Health & Science University in Portland. It was published online on August 18 in JAMA Network Open. LIMITATIONS: The researchers acknowledged that despite adjusting for key covariates, unmeasured confounding may persist, particularly regarding fertility preferences or sexual behavior. Additionally, this analysis reflects early uptake following a change in method availability, and longer-term data will be needed to assess continuation, adherence, and impact on unintended pregnancy rates. DISCLOSURES: Maria Rodriguez, MD, MPH, reported receiving personal fees from the World Health Organization and grants from Perrigo outside the submitted work. The study was supported by an award from Arnold Ventures. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Associated Press
16 hours ago
- Associated Press
Apollo Biowellness, Inc., Corporate Update
North Bergen, New Jersey--(Newsfile Corp. - August 18, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the 'Company'), is pleased to announce that it has been approved to file on OTCIQ. The Company is also providing the following updates. [ This image cannot be displayed. Please visit the source: ] To view an enhanced version of this graphic, please visit: The Company is in final negotiations with an Israeli based Bio-Tech and Biologics manufacturer, listed on NASDAQ, for the co-development of our shelf-stable biologic cosmetic, which is planned to be launched in the 4 th Quarter of 2025. The shelf-stable biologic cosmetic is to be known as Ceilo Skin Care, and will be sold through retail, direct-to-consumer and e-commerce platforms. In addition, the Company is in negotiations with a large aesthetic company in the business of Laser Energy Devices and products that are marketed and sold to Plastic Surgeons, Dermatologists, Med Spa's and Aesthetic Clinicians. The negotiations are for the purpose of a business combination or potential merger to create a combination therapy company, where we will sell Biologics and Aesthetic devices hand-in-glove. Also, before the end of the 3 rd Quarter of 2025, Apollo will launch the first of its kind Pet and Veterinarian Biologic, using exosomes and placental products, for Pets, via a Doctor branded product, sold exclusively through licensed Veterinarians, Clinicians and Pet Professionals. This product will be using 100% natural biologic products to treat pets for arthritis issues, joint issues, inflammation issues and skin issues. Our product will include topical and injectable therapeutics. The Company will be releasing more details as they become relevant regarding these events in the days and weeks to come, and in parallel with these actions, the Company is also working with its Debt Holders and Convertible Note Holders to either restructure, refinance or convert the majority of the positions to a preferred class of equity. This is line with the plan of management to coordinate financing for the Company to allow the plans for growth for the next 12 months. James W. Zimbler, President and CEO, stated, 'I am very eager for the new start for our biologic products company, along with the potential for new areas of activity. I anticipate an exciting next 12 months for the Company.' The Company uses the following handle on X at @ApolloBioKOAN to communicate with its shareholders About Apollo Biowellness, Inc. Apollo Biowellness, Inc., and its subsidiary, Evolutionary Biologics, Inc., is engaged in the discovery, development and marketing of products designed to better mankind. We believe we are positioning our company as a leader in the field of Regenerative Medicine as defined by the National Institute of Health using biologic based products. Intended products are to be marketed under third-party label exemptions. We are focusing our current efforts on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. Also, we are licensed under a patent-pending application to market a dual acting all-natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Products are being developed for consumer and professional markets. Before using any of our products, you should always consult with your veterinarian and/or family doctor. Forward-Looking StatementsCorporate Contact James W. Zimbler President/CEO/Director [email protected] 631-806-1420 X at @ApolloBioKOAN To view the source version of this press release, please visit